Full Text:   <2051>

CLC number: 

On-line Access: 


Revision Accepted: 

Crosschecked: 0000-00-00

Cited: 0

Clicked: 2062

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Bio-Design and Manufacturing  2018 Vol.1 No.2 P.89-100


3D biofabrication for tubular tissue engineering

Author(s):  Ian Holland, Jack Logan, Jiezhong Shi, Christopher McCormick, Dongsheng Liu, Wenmiao Shu

Affiliation(s):  Department of Biomedical Engineering, University of Strathclyde, Glasgow G1 1QE, UK; more

Corresponding email(s):   liudongsheng@mail.tsinghua.edu.cn, will.shu@strath.ac.uk

Key Words:  Tubular organs Tissue engineering 3D printing Bio-inks

Share this article to: More

Ian Holland,Jack Logan,Jiezhong Shi,Christopher McCormick,Dongsheng Liu,Wenmiao Shu . 3D biofabrication for tubular tissue engineering[J]. Journal of Zhejiang University Science D, 2018, 1(2): 89-100.

@article{title="3D biofabrication for tubular tissue engineering",
author="Ian Holland,Jack Logan,Jiezhong Shi,Christopher McCormick,Dongsheng Liu,Wenmiao Shu ",
journal="Journal of Zhejiang University Science D",
publisher="Zhejiang University Press & Springer",

%0 Journal Article
%T 3D biofabrication for tubular tissue engineering
%A Ian Holland
%A Jack Logan
%A Jiezhong Shi
%A Christopher McCormick
%A Dongsheng Liu
%A Wenmiao Shu
%J Journal of Zhejiang University SCIENCE D
%V 1
%N 2
%P 89-100
%@ 1869-1951
%D 2018
%I Zhejiang University Press & Springer
%DOI 10.1007/s42242-018-0013-2

T1 - 3D biofabrication for tubular tissue engineering
A1 - Ian Holland
A1 - Jack Logan
A1 - Jiezhong Shi
A1 - Christopher McCormick
A1 - Dongsheng Liu
A1 - Wenmiao Shu
J0 - Journal of Zhejiang University Science D
VL - 1
IS - 2
SP - 89
EP - 100
%@ 1869-1951
Y1 - 2018
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1007/s42242-018-0013-2

The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced autoimmune response, high anatomical accuracy, long-term patency and growth potential. The advent of 3D bioprinting technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro- and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Open peer comments: Debate/Discuss/Question/Opinion


Please provide your name, email address and a comment

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE